An ordinary Wyoming investment-adviser representative files Form U4 through IARD or CRD and pays $45 initially and annually unless the exact statutory dual-registration exception applies. The ordinary examination route is Series 65 or Series 66 plus Series 7. Current good-standing CFP, ChFC or MSFS, CFA, PFS, or CIC designations and specified recent-registration conditions can waive the examination requirement. Registration must be effective before activity begins.

Prelicensing education

Education requirement explanation
Qualification and any accepted alternative or waiver must match the current state rule; examination passage alone is not registration.

Background

Fingerprint / background instructions
Form U4 disclosures and regulator follow-up apply; no separate fingerprint requirement is inferred unless expressly documented.

Application

Application fee
Current official authority supports a $45 initial fee and $45 annual renewal fee; the dual-path exception is not the ordinary-applicant fee.
Application channel / system
The firm files Form U4 through IARD or CRD; filing and qualification do not create registration.
Official application reference
https://sos.wyo.gov/Investing/IARepresentatives.aspx

Renewal & maintenance

CE hours
FINRA, state, and firm continuing-education duties depend on effective registrations and current rules.

Portability

Portability / mobility notes
Registration is firm-, function-, and jurisdiction-specific; examination validity and approval are separate.

Military / veteran / spouse

Military experience / education credit
No broad military credit is asserted unless expressly documented.

Source governance

Primary authoritative source
https://sos.wyo.gov/Media/2023/002-12142023-Securities-Rules-Chpts-2-4-5-10.pdf
Last verified date
2026-08-31
Verification status
Verified
Review / recheck date
2026-09-30

Compare education providers

Alphabetical options; compensation never determines eligibility or placement. Confirm the exact course and jurisdiction before enrolling. This directory is not exhaustive.

No currently verified published offerings match. Check official provider and regulator resources; additional options may exist.